PYPD
PolyPid Ltd.
Price Chart
Latest Quote
$4.74
| Previous Close | $4.56 |
| Open | $4.56 |
| Day High | $4.83 |
| Day Low | $4.56 |
| Volume | 101,277 |
Stock Information
| Shares Outstanding | 19.17M |
| Total Debt | $2.34M |
| Cash Equivalents | $10.91M |
| Net Income | $-33.63M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $90.89M |
| EPS (TTM) | $-1.72 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $82.32M |
| Income | $-33.63M |
| Book/sh | $0.46 |
| Cash/sh | $0.57 |
| Employees | 69 |
Financial Ratios
| Quick Ratio | 1.55 |
| Current Ratio | 1.78 |
| Debt/Eq | 26.69 |
Returns & Margins
| ROA | -115.07% |
| ROE | -758.61% |
Ownership
| Insider Ownership | 21.23% |
| Institutional Ownership | 34.85% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.78 |
| P/B | 10.35 |
Analyst Data
| Recommendation | none |
| Target Price | $12.25 |
Technical Indicators
| SMA20 | $4.72 |
| SMA50 | $4.61 |
| SMA200 | $4.14 |
| RSI | 50.55 |
| ATR | 0.2906 |
| Shares Float | 10.91M |
| Short Float | 0.98% |
| Short Ratio | 1.29 |
| Volatility | 1.43 |
| Rel Volume | 0.74 |
Performance History
| Week | +3.72% |
| Month | -0.42% |
| Quarter | +8.47% |
| 6 Months | +20.00% |
| YTD | +8.97% |
| Year | +34.28% |
| 3 Years | -62.29% |
| 5 Years | -98.30% |
| 10 Years | -99.17% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $4.74 | 101,300 |
| 2026-06-17 | $4.56 | 24,300 |
| 2026-06-16 | $4.66 | 58,200 |
| 2026-06-15 | $4.66 | 33,800 |
| 2026-06-12 | $4.62 | 61,900 |
| 2026-06-11 | $4.57 | 103,100 |
| 2026-06-10 | $4.51 | 52,100 |
| 2026-06-09 | $4.57 | 69,100 |
| 2026-06-08 | $4.62 | 68,600 |
| 2026-06-05 | $4.50 | 215,100 |
| 2026-06-04 | $4.83 | 170,300 |
| 2026-06-03 | $4.72 | 202,800 |
| 2026-06-02 | $4.87 | 197,200 |
| 2026-06-01 | $5.07 | 370,700 |
| 2026-05-29 | $4.72 | 55,300 |
| 2026-05-28 | $4.76 | 157,100 |
| 2026-05-27 | $4.77 | 238,700 |
| 2026-05-26 | $4.84 | 149,000 |
| 2026-05-22 | $5.02 | 198,500 |
| 2026-05-21 | $4.83 | 223,800 |
| 2026-05-20 | $4.85 | 214,600 |
| 2026-05-19 | $4.76 | 108,100 |
About PolyPid Ltd.
PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
đ° Latest News
PolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus.com âĸ 2026-05-13T23:01:13ZPolyPid Ltd. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-13T20:58:19ZPolyPid (PYPD) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-13T19:01:43ZPolyPid Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T18:09:38ZPolyPid Q1 2026 Earnings Call: Complete Transcript
Benzinga âĸ 2026-05-13T13:24:39ZWhen Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit?
Simply Wall St. âĸ 2026-02-13T10:24:49ZPolyPid Ltd. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-12T13:30:00ZPolyPid Ltd (PYPD) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges
GuruFocus.com âĸ 2026-02-11T21:03:20ZPolyPid (PYPD) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-02-11T18:49:53ZPolyPid Q4 Earnings Call Highlights
MarketBeat âĸ 2026-02-11T14:52:18ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $874,000 | $1,510,000 | $1,618,000 | $540,000 |
| Total Expenses | $32,967,000 | $28,029,000 | $22,867,000 | $38,888,000 |
| Other Income Expense | $-838,000 | $113,000 | $234,000 | $532,000 |
| Net Non Operating Interest Income Expense | $-359,000 | $-1,064,000 | $-1,163,000 | $-540,000 |
| Total Other Finance Cost | $2,000 | $-4,000 | $93,000 | $316,000 |
| Interest Expense Non Operating | $874,000 | $1,510,000 | $1,618,000 | $540,000 |
| Operating Expense | $32,967,000 | $28,029,000 | $22,867,000 | $38,888,000 |
| Selling And Marketing Expense | $1,977,000 | $945,000 | $1,196,000 | $2,888,000 |
| General And Administrative Expense | $7,183,000 | $4,273,000 | $5,523,000 | $8,010,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Net Interest Income | $-359,000 | $-1,064,000 | $-1,163,000 | $-540,000 |
| Interest Income | $517,000 | $442,000 | $548,000 | $267,000 |
| Normalized Income | $-33,331,000 | $-29,109,010 | $-24,045,180 | $-39,557,000 |
| Net Income From Continuing And Discontinued Operation | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Total Operating Income As Reported | $-32,967,000 | $-28,029,000 | $-22,867,000 | $-38,888,000 |
| Net Income Common Stockholders | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Net Income | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Net Income Including Noncontrolling Interests | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Net Income Continuous Operations | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Pretax Income | $-34,164,000 | $-28,980,000 | $-23,796,000 | $-39,428,000 |
| Special Income Charges | $-512,000 | $0 | $0 | - |
| Interest Income Non Operating | $517,000 | $442,000 | $548,000 | $267,000 |
| Operating Income | $-32,967,000 | $-28,029,000 | $-22,867,000 | $-38,888,000 |
| Per Share | ||||
| Diluted EPS | $-2.09 | $-4.91 | $-16.99 | $-60.90 |
| Basic EPS | $-2.09 | $-4.91 | $-16.99 | $-60.90 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $25,990 | $53,820 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-30,994,000 | $-25,961,000 | $-20,590,000 | $-37,167,000 |
| Total Unusual Items | $-838,000 | $113,000 | $234,000 | $532,000 |
| Total Unusual Items Excluding Goodwill | $-838,000 | $113,000 | $234,000 | $532,000 |
| Reconciled Depreciation | $1,458,000 | $1,622,000 | $1,822,000 | $1,721,000 |
| EBITDA (Bullshit earnings) | $-31,832,000 | $-25,848,000 | $-20,356,000 | $-37,167,000 |
| EBIT | $-33,290,000 | $-27,470,000 | $-22,178,000 | $-38,888,000 |
| Diluted Average Shares | $16,351,890 | $5,912,890 | $1,421,308 | $647,556 |
| Basic Average Shares | $16,351,890 | $5,912,890 | $1,404,368 | $647,556 |
| Diluted NI Availto Com Stockholders | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Tax Provision | $5,000 | $42,000 | $69,000 | $129,000 |
| Other Special Charges | $512,000 | - | - | - |
| Gain On Sale Of Security | $-326,000 | $113,000 | $234,000 | $532,000 |
| Research And Development | $23,807,000 | $22,811,000 | $16,148,000 | $27,990,000 |
| Selling General And Administration | $9,160,000 | $5,218,000 | $6,719,000 | $10,898,000 |
| Other Gand A | $7,183,000 | $4,273,000 | $5,523,000 | $8,010,000 |
| Otherunder Preferred Stock Dividend | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $10,973,000 | $7,684,000 | $-2,096,000 | $5,829,000 |
| Total Assets | $22,307,000 | $25,220,000 | $15,372,000 | $25,971,000 |
| Total Non Current Assets | $7,080,000 | $8,647,000 | $9,305,000 | $11,777,000 |
| Other Non Current Assets | $311,000 | $277,000 | $87,000 | $99,000 |
| Current Assets | $15,227,000 | $16,573,000 | $6,067,000 | $14,194,000 |
| Other Current Assets | $632,000 | $434,000 | $106,000 | $537,000 |
| Restricted Cash | $193,000 | $168,000 | $300,000 | $511,000 |
| Prepaid Assets | $363,000 | $330,000 | $352,000 | $552,000 |
| Inventory | $1,106,000 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $12,933,000 | $15,641,000 | $5,309,000 | $12,594,000 |
| Cash And Cash Equivalents | $6,402,000 | $15,641,000 | $5,309,000 | $8,552,000 |
| Receivables | - | - | - | $298,000 |
| Other Receivables | - | - | - | $298,000 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $2,796,000 | $9,617,000 | $11,779,000 | $13,730,000 |
| Long Term Debt And Capital Lease Obligation | $647,000 | $1,911,000 | $7,236,000 | $8,747,000 |
| Current Debt And Capital Lease Obligation | $2,149,000 | $7,706,000 | $4,543,000 | $4,983,000 |
| Current Debt | $988,000 | $6,787,000 | $4,003,000 | $4,024,000 |
| Other Current Borrowings | $988,000 | $6,787,000 | $4,003,000 | $4,024,000 |
| Long Term Debt | - | $634,000 | $6,379,000 | $7,574,000 |
| Net Debt | - | - | $5,073,000 | $3,046,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $11,334,000 | $17,536,000 | $17,468,000 | $20,142,000 |
| Total Non Current Liabilities Net Minority Interest | $3,595,000 | $4,855,000 | $10,182,000 | $11,589,000 |
| Other Non Current Liabilities | $400,000 | $396,000 | $398,000 | $294,000 |
| Non Current Deferred Liabilities | $2,548,000 | $2,548,000 | $2,548,000 | $2,548,000 |
| Current Liabilities | $7,739,000 | $12,681,000 | $7,286,000 | $8,553,000 |
| Other Current Liabilities | $8,000 | $23,000 | $18,000 | $16,000 |
| Payables And Accrued Expenses | $5,582,000 | $4,952,000 | $2,725,000 | $3,554,000 |
| Payables | $2,856,000 | $2,409,000 | $772,000 | $1,141,000 |
| Accounts Payable | $2,856,000 | $2,409,000 | $772,000 | $1,141,000 |
| Current Deferred Liabilities | - | - | - | $0 |
| Other Payable | - | - | - | $16,000 |
| Equity | ||||
| Common Stock Equity | $10,973,000 | $7,684,000 | $-2,096,000 | $5,829,000 |
| Total Equity Gross Minority Interest | $10,973,000 | $7,684,000 | $-2,096,000 | $5,829,000 |
| Stockholders Equity | $10,973,000 | $7,684,000 | $-2,096,000 | $5,829,000 |
| Retained Earnings | $-301,500,000 | $-267,331,000 | $-238,309,000 | $-214,444,000 |
| Other | ||||
| Ordinary Shares Number | $18,204,002 | $10,190,904 | $1,653,559 | $661,727 |
| Share Issued | $18,204,002 | $10,190,904 | $1,653,559 | $661,727 |
| Tangible Book Value | $10,973,000 | $7,684,000 | $-2,096,000 | $5,829,000 |
| Invested Capital | $11,961,000 | $15,105,000 | $8,286,000 | $17,427,000 |
| Working Capital | $7,488,000 | $3,892,000 | $-1,219,000 | $5,641,000 |
| Capital Lease Obligations | $1,808,000 | $2,196,000 | $1,397,000 | $2,132,000 |
| Total Capitalization | $10,973,000 | $8,318,000 | $4,283,000 | $13,403,000 |
| Additional Paid In Capital | $312,473,000 | $275,015,000 | $236,213,000 | $220,273,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $2,548,000 | $2,548,000 | $2,548,000 | $2,548,000 |
| Long Term Capital Lease Obligation | $647,000 | $1,277,000 | $857,000 | $1,173,000 |
| Current Capital Lease Obligation | $1,161,000 | $919,000 | $540,000 | $959,000 |
| Current Accrued Expenses | $2,726,000 | $2,543,000 | $1,953,000 | $2,413,000 |
| Net PPE | $6,769,000 | $8,370,000 | $9,218,000 | $11,678,000 |
| Accumulated Depreciation | $-10,877,000 | $-9,419,000 | $-7,797,000 | $-5,975,000 |
| Gross PPE | $17,646,000 | $17,789,000 | $17,015,000 | $17,653,000 |
| Leases | $6,567,000 | $6,524,000 | $6,503,000 | $6,503,000 |
| Other Properties | $10,116,000 | $10,462,000 | $9,719,000 | $10,364,000 |
| Machinery Furniture Equipment | $963,000 | $803,000 | $793,000 | $786,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $6,531,000 | $0 | $0 | $4,042,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Deferred Revenue | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-28,089,000 | $-22,039,000 | $-17,432,000 | $-36,084,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-27,879,000 | $-21,963,000 | $-17,236,000 | $-34,317,000 |
| Cash Flow From Continuing Operating Activities | $-27,879,000 | $-21,963,000 | $-17,236,000 | $-34,317,000 |
| Operating Gains Losses | $512,000 | - | $-201,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-210,000 | $-76,000 | $-196,000 | $-1,767,000 |
| Investing Cash Flow | $-6,704,000 | $-330,000 | $3,804,000 | $16,575,000 |
| Cash Flow From Continuing Investing Activities | $-6,704,000 | $-330,000 | $3,804,000 | $16,575,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $32,603,000 | $35,863,000 | $12,710,000 | $5,011,000 |
| Financing Cash Flow | $25,369,000 | $32,416,000 | $9,976,000 | $16,428,000 |
| Cash Flow From Continuing Financing Activities | $25,369,000 | $32,416,000 | $9,976,000 | $16,428,000 |
| Net Other Financing Charges | $-859,000 | $-125,000 | $-125,000 | - |
| Net Common Stock Issuance | $32,603,000 | $35,863,000 | $12,710,000 | $5,011,000 |
| Common Stock Issuance | $32,603,000 | $35,863,000 | $12,710,000 | $5,011,000 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-6,376,000 | $-3,322,000 | $-2,618,000 | $-402,000 |
| Interest Paid Supplemental Data | $557,000 | $950,000 | $1,038,000 | $734,000 |
| Income Tax Paid Supplemental Data | $5,000 | $3,000 | $18,000 | $8,000 |
| End Cash Position | $6,595,000 | $15,809,000 | $5,686,000 | $9,142,000 |
| Beginning Cash Position | $15,809,000 | $5,686,000 | $9,142,000 | $10,456,000 |
| Changes In Cash | $-9,214,000 | $10,123,000 | $-3,456,000 | $-1,314,000 |
| Proceeds From Stock Option Exercised | $1,000 | $0 | $9,000 | $108,000 |
| Net Issuance Payments Of Debt | $-6,376,000 | $-3,322,000 | $-2,618,000 | $11,309,000 |
| Net Long Term Debt Issuance | $-6,376,000 | $-3,322,000 | $-2,618,000 | $11,309,000 |
| Long Term Debt Payments | $-6,376,000 | $-3,322,000 | $-2,618,000 | $-402,000 |
| Net Investment Purchase And Sale | $-6,494,000 | $-254,000 | $4,000,000 | $18,342,000 |
| Sale Of Investment | $19,722,000 | $21,099,000 | $22,600,000 | $25,342,000 |
| Purchase Of Investment | $-26,216,000 | $-21,353,000 | $-18,600,000 | $-7,000,000 |
| Net PPE Purchase And Sale | $-210,000 | $-76,000 | $-196,000 | $-1,767,000 |
| Purchase Of PPE | $-210,000 | $-76,000 | $-196,000 | $-1,767,000 |
| Change In Working Capital | $359,000 | $1,916,000 | $-110,000 | $-1,077,000 |
| Change In Other Current Liabilities | $-675,000 | $-723,000 | $-494,000 | $2,132,000 |
| Change In Other Current Assets | $907,000 | $824,000 | $593,000 | $-2,431,000 |
| Change In Payables And Accrued Expense | $352,000 | $2,130,000 | $-850,000 | $-4,511,000 |
| Change In Accrued Expense | $172,000 | $493,000 | $-481,000 | $-1,416,000 |
| Change In Payable | $180,000 | $1,637,000 | $-369,000 | $-3,095,000 |
| Change In Account Payable | $180,000 | $1,637,000 | $-369,000 | $-3,095,000 |
| Change In Prepaid Assets | $-225,000 | $-315,000 | $641,000 | $1,185,000 |
| Other Non Cash Items | $-893,000 | $697,000 | $1,727,000 | $289,000 |
| Stock Based Compensation | $4,854,000 | $2,824,000 | $3,391,000 | $4,307,000 |
| Depreciation Amortization Depletion | $1,458,000 | $1,622,000 | $1,822,000 | $1,721,000 |
| Depreciation And Amortization | $1,458,000 | $1,622,000 | $1,822,000 | $1,721,000 |
| Depreciation | $1,458,000 | $1,622,000 | $1,822,000 | $1,721,000 |
| Net Income From Continuing Operations | $-34,169,000 | $-29,022,000 | $-23,865,000 | $-39,557,000 |
| Issuance Of Debt | - | $0 | $0 | $11,711,000 |
| Long Term Debt Issuance | - | $0 | $0 | $11,711,000 |
| Gain Loss On Investment Securities | - | - | $-201,000 | - |
| Change In Other Working Capital | - | - | - | $2,548,000 |